LD-2 disclosure · 3rd Quarter - Report
AEGLEA BIOTHERAPEUTICS, INC.
Income$30Kfee reported
Client
- Name
- AEGLEA BIOTHERAPEUTICS, INC.
- Description
- Clinical-stage biotechnology company; designs and develops human enzyme therapeutics
- Location
- Texas · United States of America
Registrant
- Description
- lobby firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
S. 670/H.R. 1730, the Speeding Therapy Access Today (STAT) Act H.R. 482/ S. 350, the Newborn Screening Saves Lives Reauthorization Act H.R. 3783/S. 2013, the Medical Nutrition Equity Act of 2021 Cures 2.0 (not introduced yet)
LobbyistsPATROSKI LAWSON · BENJAMIN MASON · KATHERINE LANDES · JACOB JACKSON
TargetedSENATE · HOUSE OF REPRESENTATIVES